SK bioscience

SK bioscience is a South Korean pharmaceutical company. It mainly engages in the production and development of vaccines. The company has registered SKYCellflu Prefilled Syringe (PFS), the first cell-cultured influenza vaccine in South Korea, and subsequently obtained licenses for SKYCellflu Quadrivalent Prefilled Syringe and 13-valent pneumococcal conjugate vaccine. Additionally, it has several other vaccines under development and clinical trials, including a recombinant rotavirus vaccine. Furthermore, it is collaborating with external partners to develop a new typhoid conjugate vaccine and an innovative pneumococcal vaccine.